Technology

The Fixed Phage technology localises and stabilises phages, opening the door to their widespread practical application.

With the increasing prevalence of antibiotic resistance, new treatments are needed. Phages offer one viable alternative but as large biological molecules they are sensitive to environmental stresses.

 

The Fixed Phage technology uses a high-voltage electrical discharge to “immobilise” (irreversibly covalently attach) phages to almost any surface.

 

This immobilisation not only retains phages at sites where they can have the maximum antibacterial effect but also has a stabilising effect, extending the viability of phages at ambient temperatures from weeks to years.

 

The Fixed Phage technology is protected by a suite of granted and pending patents in all important global marketplaces.

The Fixed Phage technology uses a high-voltage electrical discharge to “immobilise” (irreversibly covalently attach) phages to almost any surface. This immobilisation not only retains phages at sites where they can have the maximum antibacterial effect but also has a stabilising effect, extending the viability of phages at ambient temperatures from weeks to years.

 

The Fixed Phage technology is cheap and clean to apply; it uses only electricity and no other chemicals or bonding agents and surfaces can be activated in a fraction of a second.

 

Almost any surface can be treated, meaning the technology is a platform that can be used in to target a wide range of bacterial problems. Currently, the company is focussing in three key areas: aquaculture, animal feed and food packing.

 

However, the technology also has applications in the fields of agriculture, human health and other areas.